<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Cyanide Antidote Kit - Medications - Offline Clinical Reference</title>
  <link rel="stylesheet" href="../style.css">
</head>
<body>
  <div class="topbar">
    <div class="topbar-inner">
      <span class="pill"><strong>Cyanide Antidote Kit</strong></span>
      <span class="spacer"></span>
      <div class="nav-btns">
        <a class="btn small" href="../../index.html">Home</a>
        <a class="btn small" href="../../index.html#/sickbay-meds">Back to Medications</a>
      </div>
    </div>
  </div>

  <main class="wrap">
    <section class="section">
      <div class="kicker">Endocrine / Metabolic / Antidotes</div>
      <h1>Cyanide Antidote Kit</h1>

      <div class="content">
        <h3>Stocked on board</h3>
        <ul>
          <li>Cyanide Antidote Kit</li>
        </ul>

        <div class="rule"></div>

        <h3>Adult dosing</h3>
        <p><strong>Suspected or confirmed acute cyanide poisoning</strong> (fire victims with smoke inhalation, altered mental status, seizures, cardiovascular collapse; industrial exposure)</p>
        <ul>
          <li><strong>Traditional two-step cyanide antidote kit (amyl nitrite + sodium nitrite + sodium thiosulfate)</strong>
            <ul>
              <li><strong>Step 1: Amyl nitrite inhalation</strong> (while IV access being established)
                <ul>
                  <li>Break 1 ampule and hold under patient's nose; inhale for 15–30 seconds every minute</li>
                  <li>Discontinue once IV sodium nitrite is ready</li>
                </ul>
              </li>
              <li><strong>Step 2: Sodium nitrite IV</strong>
                <ul>
                  <li>300 mg (10 mL of 3% solution) IV over 5–10 minutes</li>
                  <li>Pediatric dosing: varies by hemoglobin level; follow kit instructions or toxicology guidance</li>
                </ul>
              </li>
              <li><strong>Step 3: Sodium thiosulfate IV</strong>
                <ul>
                  <li>12.5 g (50 mL of 25% solution) IV over 10–30 minutes</li>
                  <li>May repeat at half the initial dose if symptoms persist or recur</li>
                </ul>
              </li>
            </ul>
          </li>
          <li><strong>Newer agent: Hydroxocobalamin (Cyanokit)</strong> (if available; preferred in many settings)
            <ul>
              <li>5 g IV over 15 minutes; may repeat 5 g dose if needed</li>
              <li>Consult product monograph or poison center for specific administration instructions</li>
            </ul>
          </li>
          <li><strong>NOTE:</strong> Treatment must be initiated immediately based on clinical suspicion; do not wait for laboratory confirmation</li>
        </ul>

        <div class="rule"></div>

        <h3>Indications</h3>
        <ul>
          <li>Known or suspected acute cyanide poisoning</li>
          <li>Common scenarios: enclosed-space fires with smoke inhalation + altered mental status/cardiovascular collapse, industrial chemical exposure, ingestion of cyanide-containing substances</li>
          <li>Clinical clues: unexplained severe lactic acidosis, altered mental status, seizures, cardiovascular instability in appropriate exposure context</li>
        </ul>

        <div class="rule"></div>

        <h3>Contraindications / cautions</h3>
        <ul>
          <li><strong>Sodium nitrite:</strong> causes methemoglobinemia by design (converts hemoglobin to methemoglobin to bind cyanide); use with extreme caution if co-existing carbon monoxide poisoning (common in fire victims)—risk of worsening hypoxia</li>
          <li>Consider hydroxocobalamin (if available) as safer alternative in smoke inhalation with possible CO exposure</li>
          <li>Hypotension risk with rapid IV nitrite administration; monitor BP closely</li>
          <li>Pregnancy: use if life-threatening; potential fetal risks from both cyanide and methemoglobin formation</li>
          <li>G6PD deficiency: increased risk of hemolysis with nitrites</li>
        </ul>

        <div class="rule"></div>

        <h3>Adverse effects</h3>
        <ul>
          <li><strong>Sodium nitrite:</strong> hypotension, tachycardia, methemoglobinemia (by design but may be excessive), headache, dizziness</li>
          <li><strong>Sodium thiosulfate:</strong> generally well tolerated; nausea, vomiting (uncommon)</li>
          <li><strong>Amyl nitrite:</strong> headache, dizziness, hypotension, flushing</li>
          <li><strong>Hydroxocobalamin:</strong> chromaturia (red-colored urine/plasma), transient hypertension, rash, nausea; can interfere with lab testing (colorimetric assays)</li>
        </ul>

        <div class="rule"></div>

        <h3>Preparation &amp; administration</h3>
        <ul>
          <li><strong>Scene safety first:</strong> ensure rescuers are protected from ongoing cyanide exposure; remove patient from source</li>
          <li>Ensure high-flow oxygen for all suspected cyanide poisoning patients</li>
          <li>Traditional kit: follow stepwise administration as above; ensure IV access before starting nitrite/thiosulfate</li>
          <li>Monitor vital signs continuously during administration</li>
          <li>Contact poison control center and medical toxicology support early (1-800-222-1222 in North America)</li>
          <li>Document exposure history, time of antidote administration, and clinical response</li>
        </ul>

        <div class="rule"></div>

        <h3>Monitoring</h3>
        <ul>
          <li>Continuous vital signs (BP, HR, oxygen saturation, ECG if available)</li>
          <li>Mental status and neurological exam</li>
          <li>Methemoglobin level if nitrites used (goal <30%; higher levels worsen oxygen delivery)</li>
          <li>Lactate/acid-base status (improvement suggests effective treatment)</li>
          <li>Co-oximetry if available (to assess both carboxyhemoglobin from CO and methemoglobin)</li>
          <li>Observe for recurrent symptoms (may require repeat thiosulfate dosing)</li>
        </ul>

        <div class="rule"></div>

        <h3>At-sea considerations</h3>
        <ul>
          <li>Cyanide poisoning is rare but rapidly fatal; high index of suspicion needed in fire victims with unexplained severe symptoms or industrial chemical exposures</li>
          <li>If diagnostic uncertainty and patient is critically ill with suspected exposure: treat empirically (risk of antidote generally lower than risk of untreated cyanide poisoning)</li>
          <li>Ensure kit is stored properly, not expired, and crew trained in recognition/administration</li>
          <li>Immediate evacuation planning: cyanide poisoning requires intensive care-level support even after antidote administration</li>
          <li>If only traditional kit available and concern for CO co-poisoning, consider consulting toxicology before nitrite administration (may preferentially use thiosulfate alone or await hydroxocobalamin)</li>
          <li>Document all exposure details, antidote doses/times, and response for receiving facility and regulatory reporting</li>
        </ul>

        <div class="rule"></div>

        <h3>Online-only references</h3>
        <ul>
          <li>Health Canada – Cyanide Antidote Kit product information: <a href="https://pdf.hres.ca/dpd_pm/00047081.PDF" target="_blank" rel="noopener">https://pdf.hres.ca/dpd_pm/00047081.PDF</a></li>
          <li>TOXNET – Cyanide poisoning management (NIH): <a href="https://www.ncbi.nlm.nih.gov/books/NBK507796/" target="_blank" rel="noopener">https://www.ncbi.nlm.nih.gov/books/NBK507796/</a></li>
          <li>American Association of Poison Control Centers: <a href="https://www.poison.org" target="_blank" rel="noopener">https://www.poison.org</a> (1-800-222-1222)</li>
          <li>BC Drug and Poison Information Centre: <a href="https://www.dpic.org" target="_blank" rel="noopener">https://www.dpic.org</a></li>
        </ul>
      </div>

      <p class="foot">
        Verify dosing and indications against current clinical guidelines.
      </p>
    </section>
  </main>
</body>
</html>
